Table 2.

Disease-free survival and overall survival results: Univariate analysis

Variable	DFS rates			OS rates
	No. of events	%	Log-rankap-value	No. of events	%	Log-rankap-value
MetS			0.008			< 0.0001
No	109	79.8		48	91.1
Yes	49	71.2		41	75.9
No. of MetS comp.b			0.02			< 0.0001
0 components	24	80.2		5	98.9
1–2 components	68	79.2		39	88.1
3–5 components	49	71.2		41	75.9
Age			0.1			< 0.0001
≤ 55 years	78	79.8		26	93.3
> 55 years	80	75.2		63	80.5
Stage			< 0.0001			< 0.0001
I–II	100	82.1		456	90.0
III	46	62.0		30	75.2
IHC-subtypes			0.001			0.04
Luminal A	52	81.2		32	88.4
Luminal B	41	79		24	87.7
HER2 positive	36	70		16	86.7
Triple negative	25	72.8		16	82.6
Therapy			< 0.0001			< 0.0001
Chemotherapy only	32	69.5		22	79.0
Hormone only	34	86.6		22	91.3
Chemo + hormone	70	78.0		29	90.9
HOMA-IR score			0.9			0.1
Normal (< 2.6)	83	77.3		51	86.1
Medium (2.6–5)	26	81.9		10	93.1
High (> 5)	19	71.2		8	87.9
Waist circumference			0.1			< 0.0001
≤ 88 cm	72	79.8		30	91.6
> 88 cm	84	75.5		58	83.1
Blood pressure			0.8			0.03
< 130; < 85 mmHg	80	78.1		40	89.0
≥ 130; ≥ 85 mmHg	64	77.5		47	83.5
HDL			0.1			0.04
≥ 50 mg/dL	93	77.6		52	87.5
< 50 mg/dL	37	72.6		26	80.7
Triglycerides			< 0.0001			< 0.0001
< 150 mg/dL	110	80.8		44	92.3
≥ 150 mg/dL	45	62.8		43	64.2
Fasting glucose			0.003			0.001
< 110 mg/dL	123	79.2		64	89.2
≥ 110 mg/dL	34	70.2		25	78.1

^aKaplan–Meier univariate analysis

^bNCEP—ATP III criteria